COVID-19 vaccination in Eswatini

Last updated

COVID-19 vaccination in Eswatini
DateMarch 19, 2021 (2021-03-19) – present
Location Eswatini
Cause COVID-19 pandemic
Motive COVID-19 pandemic in Eswatini

COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Contents

Eswatini began its vaccination program on 19 March 2021. In early May 2021, it was reported that Eswatini had administered all of the doses it had so far received. [1]

Background

History

Timeline

March 2021

  • March 2021: Eswatini receives 20,000 of the Oxford-AstraZeneca/Covishield vaccine, donated by India, and 12,000 doses of the same vaccine through COVAX.[ citation needed ]
  • 19 March 2021: launch of targeted vaccination campaign.[ citation needed ]
  • By the end of March, 9,871 vaccine doses had been administered.

April 2021

  • By the end of April, 34,897 vaccine doses had been administered.

May 2021

  • By the end of May, 34,897 vaccine doses had been administered.

June 2021

  • By the end of June, 34,897 vaccine doses had been administered.

July 2021

  • 27 July 2021: Eswatini receives 300,000 doses of the Janssen COVID-19 vaccine donated by the United States.
  • By the end of July, 66,553 vaccine doses had been administered and 27,227 persons fully vaccinated (6% of the targeted population).

August 2021

  • 3 August 2021: launch of general vaccination campaign.
  • By the end of August, 189,424 vaccine doses had been administered and 150,535 persons fully vaccinated (32% of the targeted population).

September 2021

  • By the end of September, 248,985 vaccine doses had been administered and 210,432 persons fully vaccinated (45% of the targeted population).

October 2021

  • By the end of October, 274,379 vaccine doses had been administered and 235,360 persons fully vaccinated (50% of the targeted population).

November 2021

  • By the end of November, 306,445 vaccine doses had been administered and 260,763 persons fully vaccinated (56% of the targeted population).

December 2021

  • By the end of December, 401,306 vaccine doses had been administered and 302,304 persons fully vaccinated (64% of the targeted population).

January 2022

  • By the end of January, 475,718 vaccine doses had been administered and 334,851 persons fully vaccinated (70% of the targeted population).

February 2022

  • By the end of February, half a million vaccine doses had been administered and 336,066 persons fully vaccinated.

March 2022

  • By the end of March, 509,424 vaccine doses had been administered and 336,066 persons fully vaccinated.

April 2022

  • By the end of April, 535,393 vaccine doses had been administered and 336,066 persons fully vaccinated.

Progress

27,226 persons had been fully vaccinated by the end of July 2021, 150,535 by the end of August, 210,432 by the end of September, 235,360 by the end of October, 260,763 by the end of November, and 401,306 (64% of the target population) by the end of December 2021.

Cumulative vaccinations in Eswatini [2]

Related Research Articles

<span class="mw-page-title-main">COVID-19 pandemic in Benin</span> Ongoing COVID-19 viral pandemic in Benin

The COVID-19 pandemic in Benin was a part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Benin in March 2020.

On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Burkina Faso</span> Plan to immunize against COVID-19

Burkina Faso started vaccinating against COVID-19 on 2 June 2021.

Cape Verde has begun vaccinations against COVID-19.

On 23 February 2021, Senegal began its national vaccination program against the COVID-19. As of 10 March, 68,205 people in Senegal have been able to be vaccinated.

<span class="mw-page-title-main">COVID-19 vaccination in Africa</span> Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered. Africa received in total less than 2% of the 3 billion vaccination doses provided globally.

<span class="mw-page-title-main">COVID-19 vaccination in Ghana</span> Plan to immunize against COVID-19

COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.

<span class="mw-page-title-main">COVID-19 vaccination in Nigeria</span> Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.

COVID-19 vaccination in Iceland is an effort to immunize the adult population of Iceland due to the COVID-19 pandemic. As of July 2021, more than 260,000 individuals had received at least one dose of COVID-19 vaccine, which was over 78% of the country's population. On November 21, 2021, 90% of the target population had been fully vaccinated, while around 1 in 5 people had received a booster on top of that; by December 9, 2021, the share of the population having received a booster shot exceeded 50%. On December 13, 2021, the country began offering Pfizer vaccinations to children aged 5–11.

COVID-19 vaccination in Burundi is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Burundi was one of the last nation states in the world to commence vaccination against COVID-19. This was mostly due to the government's refusal to vaccinate the population throughout most of 2021. In February 2021, Thaddee Ndikumana, the health minister of Burundi, said his country was more concerned with prevention measures. "Since more than 95% of patients are recovering, we estimate that the vaccines are not yet necessary," local media reported.

COVID-19 vaccination in Cameroon is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Chad is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the Central African Republic is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Ukraine</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.

References

  1. McKenzie, David; Formanek, Ingrid (8 May 2021). "Countries in Africa fear they could become the next India as vaccine supplies dwindle". CNN. Retrieved 8 May 2021.
  2. "owid/covid-19-data". GitHub. Retrieved 7 March 2021.